Joint development and licensing of technologies
Release of a new type of own branded inhalers.

Increasing market share by bringing a highly competitive product to the market.

Additional sales channel through partnerships with pharmaceutical companies.

Connection of the company's products to the PM&HM medical technology platform.

An additional image for a manufacturer of "gentle treatment" equipment using the latest digital technologies and telemedicine.

Minimum production and sales support capital expenditures (CapEx).

Production of "non-counterfeitable" inhalers for their use with "non-counterfeitable" drugs.
We offer Russian and foreign medical device manufacturers cooperation in a joint production of PM&HM inhalers.
Potential benefits for digital partners:
For more information, please contact us in any way convenient for you.